Dublin, June 25, 2018 (GLOBE NEWSWIRE) -- The "United States Anesthesia Drugs Market, By Type [General Inhalation Anesthesia, General Intravenous Anesthesia and Local Anesthesia], Companies" report has been added to ResearchAndMarkets.com's offering. United States Anesthesia Drugs Market is projected to reach US$ 5 Billion by the year 2024 owing to the increasing prevalence of cardiovascular cases, rising geriatric population and growing number of urgent surgeries in the United States. he different types of anesthesia are Local Anesthesia, General Inhalation Anesthesia and General Intravenous Anesthesia. Local Anesthesia and General Anesthesia are the two commonly used types of anesthesia. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation. Furthermore, the public and private health insurers' consideration of adding anesthetic products in their reimbursement policy is expected to boost the US anesthesia drugs market in the recent years.
All Major Companies Losing their Market Share In United States all established companies are losing their market share. Primarily because anesthesia drugs are mostly sold in generic form as it is available in the low cost. The companies studied in the report are Baxter International Inc, Endo International plc & AbbVie. Today, with the help of anesthesia medical facilities, performs various surgeries to treat patient's deformities in the field of trauma, cardiovascular, gastrointestinal, urological, orthopedics, ophthalmology, neurology, oncology and cosmetics. The report titled United States Anesthesia Drugs Market, By Type [General Inhalation Anesthesia, General Intravenous Anesthesia (Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate & Fentanyl) and Local Anesthesia (Articaine, Bupivacaine, Lidocaine, Mepivacaine & Prilocaine], Companies (Baxter International, Endo International plc, AbbVie & Others) provides a complete analysis of United States Anesthesia Drugs Market. By Type - General Intravenous Anesthesia leads the Market but Local Anesthesia Drugs is the Future The report studies the market of the following Anesthesia Drugs segments: General Inhalation Anesthesia, General Intravenous Anesthesia can be further subdivided into (Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate & Fentanyl), Among these anesthesia, Propofol and Benzodiazepines Class are the leading anesthesia drugs. Local Anesthesia is further segmented into (Articaine, Bupivacaine, Lidocaine, Mepivacaine & Prilocaine). Among these Articaine and Lidocaine have good market share. Companies Analysis Baxter International, Endo International plc, and AbbVie are some of the top companies operating in the United States Anesthesia Drugs Market; which has been studied thoroughly in the report. This market research report provides a complete analysis of the United States Anesthesia Drugs Market and their projections for the upcoming years, Growth Drivers, Challenges, and Reimbursement policy.
This Report provides the answer of following Questions:
- What will be the United States Anesthesia Drugs Market by 2024?
- What will be the United States Local Anesthesia Drugs Market for the year 2024?
- What was the United States General Inhalation Anesthesia Drugs Market in 2017?
- Among General Inhalation, General Intravenous and Local Anesthesia; which one is driving the United States Anesthesia Drugs Market?
- What are the key driving forces for United States Anesthesia Drugs Market?
- What are the key challenges to United States Anesthesia Drugs Market?
Key Topics Covered:
1. Executive Summary 2. United States Anesthesia Drugs Market 3. Market Share - United States Anesthesia Drugs 3.1 Anesthesia Drugs 3.2 General Intravenous Anesthesia Drugs 3.3 Local Anesthesia Drugs 3.4 Company 4. Market - United States Anesthesia Drugs Types 4.1 General Inhalation Anesthesia Drugs Market 4.2 General Intravenous Anesthesia Drugs Market 4.3 Local Anesthesia Drugs Market 5. Market - General Intravenous Anesthesia Drugs 5.1 Propofol 5.2 Benzodiazepines Class (Diazepam and Midazolam) 5.3 Fospropofol Disodium 5.4 Ketamine 5.5 Methohexital Sodium 5.6 Pentobarbital 5.7 Etomidate 5.8 Fentanyl 6. Market - Local Anesthesia Drugs 6.1 Articaine 6.2 Bupivacaine 6.3 Lidocaine 6.4 Mepivacaine 6.5 Prilocaine 7. Companies - United States Anesthesia Drugs Market 7.1 Baxter International Inc. Anesthesia Drugs Sales 7.2 Endo International plc Anesthesia Drugs Sales 7.3 AbbVie Anesthesia Drugs Sales 7.4 Other Companies Anesthetic Drugs Sales 8. Merger & Acquisition (M&A) - United States Anesthesia 9. Reimbursement Policy - Private Health Insurance Providers 9.1 Aetna International 9.2 Coventry Health Care 9.3 Anthem Blue Cross and Blue Shield 9.4 Blue Cross and Blue Shield of Texas 9.5 UnitedHealthcare 9.5.1 State Exceptions 10. Reimbursement Policy - Public Health Insurance Providers 10.1 Medicare 10.2 MDWise 11. Growth Drivers 11.1 Growing Demand for Anesthesia Service 11.2 Rise in Ageing Population & Prevalence of Cardiovascular Disease in United States 12. Challenges 12.1 Un-match Anesthesia Providers in United States 12.2 Shortage of Anesthesia Drugs in United States
For more information about this report visit https://www.researchandmarkets.com/research/3...tates?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Infusions and Injectables , Anesthetic Drugs
